We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
277 hedge funds and large institutions have $7.86B invested in Alnylam Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 111 increasing their positions, 79 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
171% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 24
59% more call options, than puts
Call options by funds: $95.3M | Put options by funds: $59.8M
41% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 79
17% more funds holding
Funds holding: 237 → 277 (+40)
17% more capital invested
Capital invested by funds: $6.73B → $7.86B (+$1.13B)
8% less funds holding in top 10
Funds holding in top 10: 12 → 11 (-1)
Holders
277
Holders Change
+40
Holders Change %
+16.88%
% of All Funds
7.46%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.3%
New
65
Increased
111
Reduced
79
Closed
24
Calls
$95.3M
Puts
$59.8M
Net Calls
+$35.5M
Net Calls Change
+$14.3M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$98.8M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$42M |
| 3 |
AWG
Alpha Wave Global
New York
|
-$39.9M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$28.9M |
| 5 |
JP Morgan Chase
New York
|
-$27.9M |
